首页> 美国卫生研究院文献>Public Health Action >Ambulatory care for multidrug-resistant tuberculosis: lessons learned in Addis Ababa Ethiopia
【2h】

Ambulatory care for multidrug-resistant tuberculosis: lessons learned in Addis Ababa Ethiopia

机译:耐多药结核病的门诊:在埃塞俄比亚亚的斯亚贝巴的经验教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Setting: Ethiopia is one of the high multidrug-resistant tuberculosis (MDR-TB) burden countries. Efforts by the National TB Programme to control MDR-TB include expanding ambulatory care.>Objective: To investigate the opportunities and challenges faced by treatment follow-up health centres (TFCs) when managing MDR-TB patients, with greater focus on recording, TB infection control (IC) and supervision practices.>Methods: A facility-based cross-sectional study was conducted by reviewing the records of all MDR-TB cases in all 25 TFCs in Addis Ababa, Ethiopia. The TB focal point, pharmacy and laboratory heads were also interviewed.>Result: A total of 221 MDR-TB patients were registered; 157 (71%) patients had been referred from one of the two treatment initiating centres. While some TFCs oversaw up to 41 patients, others had just one patient. The majority of the TFCs (n = 21, 84%) followed standardised TB IC procedures. Poor documentation of patient information was observed at all sites; for example, human immunodeficiency virus and current treatment status was not indicated for respectively 86 (38%) and 41 (18%) patients.>Conclusion: The study revealed that infection prevention practices were largely adhered to. Documentation of patient-related information was a major challenge, and regular supervision of the TFCs should be emphasised. Record keeping is critical.
机译:>环境:埃塞俄比亚是多重耐药结核病高负担国家之一。国家结核病规划控制耐多药结核病的努力包括扩大门诊治疗。>目的:调查在管理耐多药结核病患者时,治疗跟进健康中心(TFC)面临的机遇和挑战。 >方法:通过回顾亚的斯所有25个TFC中所有耐多药结核病病例的记录,进行了基于设施的横断面研究埃塞俄比亚阿巴巴。 >结果:总共登记了221名耐多药结核病患者;其中221名耐多药结核病患者登记在册。从两个治疗发起中心之一中转诊了157名患者(71%)。虽然一些TFC监督了多达41位患者,但其他TFC只有一名患者。大多数TFC(n = 21,84%)遵循标准化的TB IC程序。在所有地点都发现患者信息记录不良;例如,未分别针对86名(38%)和41名(18%)患者指出人免疫缺陷病毒和当前治疗状态。>结论:该研究表明,在预防感染方面已得到严格遵守。与患者有关的信息的记录是一个重大挑战,应强调对TFC的定期监督。保持记录至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号